TrialThe Lancet. Infectious diseases2020

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.

David I Bernstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.